Podcast thumbnail for Invent: Life Sciences

Invent: Life Sciences

Claim This Podcast

by TTP plc

4.9(7 reviews)
30 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇬🇧
40

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality67
Social0
YouTube0
Engagement32

Podcast Overview

What are the biggest challenges and opportunities facing the life sciences sector? How can we overcome these challenges while unlocking the opportunities? Join host Stuart Lowe and a roster of expert guests as they unpack the past, present and future of cell and gene therapy.

Language

🇺🇲

Publishing Since

5/24/2022

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

40

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality67
Social0
YouTube0
Engagement32
8
Excellent Areas
1
Good Performance
10
Growth Opportunities
excellent
Episode Length
16 minutes
Performing excellently!
good
iTunes Tags
6.5/10

Recommendations available

Unlock the full report to see detailed tips

poor
Publishing Consistency
Every 45 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for Invent: Life Sciences

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Lessons from Season 3

October 20, 2025

Lessons from Season 3

<p><span style="background-color: transparent;">In Season 3 of </span>Invent: Life Sciences<span style="background-color: transparent;">, we explored the forces redefining how tomorrow’s therapies will be developed, made, and delivered. From the challenges of scaling cell and gene therapy manufacturing to the transformative power of sustainability and AI, this season uncovered what it truly takes to move from discovery to delivery.</span></p><p><br></p><p><span style="background-color: transparent;">Featuring insights from leaders across Novartis, Cellular Origins, Orchard Therapeutics, Charles River, Cytiva, OmniaBio, Eli Lilly, and more,&nbsp; this season revealed how the biotech industry must evolve to make breakthrough therapies accessible, affordable, and ready for global deployment.</span></p><p><br></p>

Episode thumbnail for Make Way for Advanced Therapies – Why Manufacturing Could be Coming to a Hospital Near You

September 22, 2025

Make Way for Advanced Therapies – Why Manufacturing Could be Coming to a Hospital Near You

<p><span style="background-color: transparent;">In our last episode, we explored the manufacturing strategies that will be key to scaling advanced therapies. Now, we turn our focus to the UK, where new regulatory frameworks and regional collaboration are changing how therapies reach patients.</span></p><p><br></p><p><span style="background-color: transparent;">Stuart speaks with leading experts about the evolution of regulation, the role of the MHRA, and why decentralized manufacturing could unlock faster, more flexible access to treatments. He also hears how Cambridge is preparing to become a regional hub for manufacturing, and what this shift could mean for patients across the East of England and beyond. Together, these perspectives reveal how regulation, clinical insight, and patient needs are converging to shape the next chapter of cell and gene therapy in the UK.</span></p><p><br></p><p><span style="background-color: transparent;">Guests:</span></p><p><br></p><ul><li><a href="linkedin.com/in/jacqueline-barry-atmp" target="_blank" style="background-color: transparent;">Jacqueline Barry</a><span style="background-color: transparent;">, Chief Clinical Officer, Cell and Gene Therapy Catapult</span></li><li><a href="https://www.linkedin.com/in/sarah-j-albon-91965858/" target="_blank" style="background-color: transparent;">Sarah Albon</a><span style="background-color: transparent;">, Director, Cambridge Cellular Therapy Laboratory at Cambridge University Hospitals NHS Foundation Trust</span></li></ul><p><br></p>

Episode thumbnail for Automation, Access, and the Future of Manufacturing

September 15, 2025

Automation, Access, and the Future of Manufacturing

<p><span style="background-color: transparent;">Manufacturing can make or break the future of cell and gene therapy. In this episode, Stuart sits down with two expert guests to share how smart design, automation, and closed systems are helping to lower costs, reduce complexity, and make therapies more accessible. From scaling strategies to operator-friendly technology, they reveal why manufacturing isn’t just a back-end process, but a critical part of therapy development from day one.</span></p><p><br></p><p><span style="background-color: transparent;">Guests:</span></p><ul><li><a href="https://www.linkedin.com/in/mark-lowdell-3b98a129/?originalSubdomain=uk" target="_blank" style="background-color: transparent;">Professor Mark Lowdell, CSO InMune Bio Inc</a></li><li><a href="https://www.linkedin.com/in/luc-henry/" target="_blank" style="background-color: transparent;">Luc Henry, Founder and CEO at Limula&nbsp;</a></li></ul><p><br></p>

30 total episodes available

Recent guests on Invent: Life Sciences

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Ryan Walker

Guest

Wenshu Xu

Guest

Deep-dive analytics for Invent: Life Sciences

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Invent: Life Sciences?

What are the biggest challenges and opportunities facing the life sciences sector? How can we overcome these challenges while unlocking the opportunities? Join host Stuart Lowe and a roster of expert guests as they unpack the past, present and future of cell and gene therapy.

How often does this podcast release new episodes?

This podcast updates bi-weekly.

Where can I listen to this podcast?

This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.